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Original Article
Sudden sensorineural hearing loss: is there a relationship
between routine haematological parameters and audiogram
shapes?
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1BioNeC Department, Universitu` degli Studi di Palermo, ENT Section, Via del Vespro, Palermo, Italy and 2Sport and Exercise Sciences
Research Unit, Universita` degli Studi di Palermo, Via Giovanni Pascoli, 6, Palermo, Italy
Abstract
Objective: To investigate the relationship between haematological routine parameters and audiogram shapes in patients affected by sudden
sensorineural hearing loss (SSNHL). Design: A retrospective study. All patients were divided into four groups according to the audiometric
curve and mean values of haematological parameters (haemoglobin, white blood cell, neutrophils and lymphocytes relative count, platelet
count, haematocrit, prothrombin time, activated partial thromboplastin time, fibrinogen and neutrophil-to-lymphocite ratio) of each group
were statistically compared. The prognostic role of blood profile and coagulation test was also examined. Study sample: A cohort of 183
SSNHL patients without comorbidities. Results: With a 48.78% of complete hearing recovery, individuals affected by upsloping hearing
loss presented a better prognosis instead of flat (18.36%), downsloping (19.23%) and anacusis (2.45%) groups (p¼ 0.0001). The
multivariate analysis of complete blood count values revealed lower mean percentage of lymphocytes (p¼ 0.041) and higher platelet levels
(p¼ 0.015) in case of downsloping hearing loss; with the exception of fibrinogen (p¼ 0.041), none of the main haematological parameters
studied resulted associated with poorer prognosis. Conclusions: Our work suggested a lack of association between haematological
parameters and a defined audiometric picture in SSNHL patients; furthermore, only fibrinogen seems to influence the prognosis of this
disease.
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Introduction
With an expected incidence of 5–30/100,000 cases per year
(Schreiber et al, 2010), sudden sensorineural hearing loss
(SSNHL) represents a challenging otological emergency whose
pathophysiology, prognosis and treatment remain not completely
understood. The most common diagnostic criteria are a sensori-
neural hearing loss of at least 30 dB over three consecutive
frequencies occurring within a 72-h period (Stachler et al, 2012).
SSNHL is generally unilateral, isolated and with variable clinical
features in terms of hearing loss degree, accompanying symptoms
and post-treatment outcomes. It was estimated that approximately
half of SSNHL patients has a complete and spontaneous hearing
recovery (Wilson et al, 1980; Filipo et al, 2013) even if a short
course of corticosteroids is generally prescribed (Kuhn et al, 2011).
It is possible to recognise a specific aetiology only in about 10%
of cases (Nosrati-Zarenoe et al, 2007; Chau et al, 2010); however, to
explain the inner ear damage, several pathogenetic mechanisms
were proposed such as vascular, viral, autoimmune, traumatic and
metabolic. Impaired cochlear perfusion remains the most supported
hypothesis due to the characteristics of inner ear circulation,
constituted by a terminal capillary bed without collateral blood
supply; vasospasm, thrombosis or vascular haemorrhage may be
responsible of a reduced cochlear blood flow with consequent
hypoxia, decrease of metabolic activity and damage of cochlear hair
cells (Mosnier et al, 2010; Martines et al, 2011). Additionally,
rheological and thrombophilic factors like high plasma viscosity,
elevated fibrinogen levels, inherited prothrombotic conditions (e.g.
hyperhomocysteinemia, Factor V Leiden mutation) and reduced
erythrocyte filterability may increase the risk of SSNHL onset
(Suckfull et al, 2002; Fusconi et al, 2012; Lovato et al, 2014).
White blood cell (WBC) count represents another peripheral
blood index frequently elevated in SSNHL patients (Mattox &
Simmons, 1977). The study of WBC subtypes and particularly of
Correspondence: Pietro Salvago, Universitu` degli Studi di Palermo, BioNeC Department, ENT Section, Via del Vespro, Palermo, 90100 Italy. Tel: 0039-091.6251473. E-mail:
pietrosalvago@libero.it
(Received 8 May 2016; accepted 9 September 2016)
ISSN 1499-2027 print/ISSN 1708-8186 online  2016 British Society of Audiology, International Society of Audiology, and Nordic Audiological Society
DOI: 10.1080/14992027.2016.1236418
Neutrophil-to-lymphocite ratio (NLR) may be a useful tool to
determine inflammation and predict prognosis in subjects with
SSNHL (Ulu et al, 2013).
Even if numerous studies previously evaluated the role of
haematological parameters as risk and prognostic factors for
SSNHL, few of them focused on their possible influence on the
audiometric profile. For example, Kanzaki et al (2014) in a
retrospective multicentre trial involving 203 SSNHL patients
evidenced a negative correlation in hearing recovery rate between
high-pitch sloping hearing loss and fibrinogen levels (p¼ 0.04) and
between anacusis and WBC (p¼ 0.03). Sagit et al (2013) and
Mirvakili et al (2016) instead found no association between hearing
loss severity and mean platelet volume (MPV) and platelet count
(PC), respectively (p40.05).
It is clear that studying the aforementioned blood parameters
values and the associated pattern of hearing damage may contribute
to a better understanding of the underlying cause of SSNHL
development. Thus, main purpose of the present study was to
investigate the relationship between haematological routine param-
eters and audiogram shapes in patients affected by SSNHL; the
prognostic role of blood profile and coagulation test was also
examined.
Materials and methods
Participants and inclusion criteria
A retrospective study was conducted at the Audiology Section of
the University of Palermo collecting medical and audiological
records from 270 patients diagnosed with SSNHL who were
admitted to our tertiary referral centre between January 2001 and
December 2014.
A careful analysis of data concerning anamnesis, micro-
otoscopy and audiometric tests was performed to exclude otological
diseases as history of middle and inner ear disease with a defined
aetiology such as trauma, infection, perilymphatic fistula, magnetic
resonance imaging (MRI)-documented retrocochlear disease (e.g.
schwannoma), exposure to ototoxic drugs, barotrauma, middle or
inner ear malformation, definite Meniere’s disease. Additionally,
the following comorbidities were used as exclusion criteria:
diabetes mellitus, coronary artery disease, congestive heart failure,
renal and/or hepatic dysfunction, arterial or venous thrombotic
disease, haematological disease, endocrine disorder and auto-
immune disease.
Subjects with SSNHL in the better or in the only hearing ear
were included when in the presence of a previous audiometry test. A
total of 183 patients who met the inclusion criteria were enrolled in
the study. Ethical Committee approved our study and a written
informed consent was obtained from all participants before the
treatment.
Haematological parameters
Haemoglobin (Hb), WBC with the relative count of neutrophils
(N%) and lymphocytes (L%), PC, haematocrit (Ht), fibrinogen,
prothrombin time (PT), activated partial thromboplastin time
(aPTT) in blood samples were measured before the treatment.
NLR was calculated as a ratio between the absolute neutrophil and
lymphocyte counts (Ulu et al, 2014). Initially, patients with
abnormal finding in glucose levels, creatinine, total cholesterol
and triglycerides were excluded. Venous blood samples were
collected into tubes containing ethylenediaminetetraacetic acid at 8
a.m. following an overnight fast.
Hearing evaluation and treatment
Air conduction pure-tone average thresholds at frequencies 0.25–
0.5-1-2-4 kHz (PTA0.25-4 kHz) were calculated for each ear (Suzuki
et al, 2015) and were used to classify hearing loss degree as follows:
mild, 21 dB or greater but less than 41 dB; moderate, 41 dB or
greater but less than 71 dB; severe, 71 dB or greater but less than
91 dB; and profound, greater than 91 dB hearing loss. Hearing
assessment was performed during the initial visit and one-month
post-treatment. Pre-treatment and post-treatment audiograms were
examined and hearing thresholds at 250, 500, 1000, 2000 and
4000 Hz were recorded. Audiogram patterns were categorised as
‘‘upsloping’’ (hearing loss affecting 250, 500 Hz more), ‘‘flat’’ (less
than 20 dB difference between the highest and the lowest threshold),
‘‘downsloping’’ (hearing loss affecting 4000, 8000 Hz more) and
‘‘anacusis’’ (thresholds of 90 dB or more in each test frequency)
(Alimoglu et al, 2011). Patients were divided into four groups
according to audiogram shape.
Criteria adopted to categorise audiological improvement were
based on those used by Furuhashi et al (2002): (1) complete
recovery: a post-treatment PTA0.25–4 kHz 25 dB H; 2) marked
improvement: a PTA0.25–4 kHz improvement 430 dB HL; (3)
slight improvement: a PTA0.25–4 kHz improvement410 dB HL but
530 dB HL; (4) nonrecovery: a PTA0.25–4 kHz improvement
510 dB HL.
All subjects were treated with oral prednisone 1 mg/kg/day
(maximum daily dose ¼60 mg) for at least 12 days; the dose was
tapered every 4 days. No patients underwent hyperbaric oxygen
therapy (HBO). Salvage intratympanic steroid injection (ITSI)
was performed after failure (slight improvement or no recovery)
in initial systemic steroid treatment since 2009. ITSI was
performed introducing a solution of 4 mg/ml dexamethasone to
fill completely the middle ear through a puncture of the
posteroinferior portion of the tympanic membrane with a 25-
gauge spinal needle. During the procedure, the patient was in the
supine position with the head tilted 45 to the unaffected side;
after the injection, patients were instructed to maintain this
position for 30 min avoiding swallowing, speaking and move-
ments of the head. ITSI was repeated once a week for a
maximum of five consecutive weeks.
Abbreviations
SSNHL sudden sensorineural hearing loss
PTA pure tone average
Hb haemoglobin
WBC white blood cell
N% neutrophils relative count




aPTT activated partial thromboplastin time
NLR neutrophil-to-lymphocite ratio
MPV mean platelet volume
PDW platelet distribution width
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Statistical analysis
Group data were expressed as percentages and quantitative
variables as mean ± standard deviations. Statistical comparisons
between two or more groups were made using 2 test and/or
Fisher’s exact test, Student’s paired t-test and analysis of
variance (ANOVA) test when appropriate. A multivariate
analysis of significance with Bonferroni’s post hoc test was
performed to study the relationship between haematological
parameters and audiogram shapes (Wilks’ effect). Significance
was set at p50.05. The STATISTICA Software, Palermo, Italy
(Vers. 8.0 for Windows) was adopted.
Results
Table 1 depicts the main demographic and clinical characteristics of
the whole sample studied. One hundred eighty-three SSNHL
patients, 101 males (55.19%) and 82 females (54.81%) were
enrolled, with a Sex ratio of 1.23 and an average age at the SSNHL
onset of 43 ± 13.73 years. Subjects were classified in four groups
according to audiogram shape: the first, composed by 41 patients
(22.4%) who suffered from an upsloping hearing loss; the second,
which included 49 individuals (26.77%) affected by a flat hearing
loss; the third and the fourth, respectively, constituted by 52
subjects (28.43%) with a downsloping hearing loss and 41 patients
(22.4%) suffering from anacusis. Groups were similar in terms of
age (p¼ 0.063) and smoking (p¼ 0.363), but different with respect
to sex (p¼ 0.005).
The evaluation of accompanying symptoms revealed a higher
percentage of vertigo (48.79%) in patients with anacusis with
respect to the others groups (p¼ 0.048). The mean duration from
the SSNHL onset to therapy was studied, resulting in 4.45 ± 2.17,
5.17 ± 2.21, 4.76 ± 2.74 and 5.93 ± 5.56 days of treatment delay,
respectively, in subjects with an upsloping hearing loss, flat hearing
loss, downsloping hearing loss and anacusis (p¼ 0.21); particularly,
the 93.44% of the total sample received a treatment within 7 days.
As shown in Figure 1, the study of mean pre-treatment
PTA0.25–4 kHz evidenced a mean hearing threshold of
50.9 ± 18.65 dB HL and 54.3 ± 18.37 dB HL in the upsloping
and downsloping groups, instead of patients with flat hearing loss
(63.25 ± 16.81 dB HL) and anacusis (105.7 ± 11.7 dB HL) who
were characterised by lower threshold values (p50.0001).
Specifically, from the comparison of the distribution of hearing
loss degree, it resulted a higher percentage (82.94%) of mild and
moderate hearing impairment in the first group with respect to
flat (51.03%) and downsloping groups (69.23%) (p¼ 0.001).
A mean hearing improvement of about 20 dB HL after therapy
was observed independently of the audiogram curves, even if
patients affected by an upsloping hearing loss presented better post-
treatment mean PTA0.25–4 kHz values (29.19 ± 16.28 dB HL)
(p50.0001). A complete PTA improvement occurred in 40 patients
(21.86%), a marked in 25 (13.66%), a slight in 41 (22.4%) whereas
no recovery was observed in 77 SSHL cases (42.08%).
Audiological evaluation of patients revealed a heterogeneous
hearing recovery with respect to the audiogram shape (Figure 2): in
fact, with a 48.78% of complete hearing recovery, individuals
suffering of upsloping hearing loss presented a better prognosis
instead of flat (18.36%), downsloping (19.23%) and anacusis
(2.45%) groups who were characterised by poorer post-treatment
outcomes (p¼ 0.0001).
Table 2 represents the main haematological parameters exam-
ined. The multivariate analysis of complete blood count values
revealed lower mean percentage of lymphocytes (21.19 ± 7.84%) in
case of downsloping hearing loss (p¼ 0.041); a statistical
Table 1. Demographic and clinical characteristics of the total cohort.
Audiogram
Cohort Upsloping Flat Downsloping Anacusis p value
No. of patients 41 (22.4) 49 (26.77) 52 (28.42) 41 (22.41)
Gender
Male 24 (58.53) 19 (38.78) 38 (73.07) 20 (49.79) 0.005
Female 17 (41.47) 30 (61.22) 14 (26.93) 21 (51.21)
Mean age 38.35 ± 10.83 45.79 ± 15.17 42.71 ± 12.85 44.54 ± 14.92 ns
Side
Left 24 (58.53) 26 (53.06) 29 (55.76) 27 (65.85) ns
Right 17 (41.47) 23 (46.94) 23 (44.24) 14 (34.15)
Smoking
Yes 16 (39.03) 14 (28.58) 23 (44.24) 13 (31.71) ns
No 25 (60.97) 35 (71.42) 29 (55.76) 28 (68.29)
Tinnitus
Yes 28 (68.29) 39 (79.59) 37 (71.15) 33 (80.48) ns
No 13 (31.71) 10 (20.41) 15 (28.85) 8 (19.52)
Vertigo
Yes 9 (21.96) 15 (30.62) 14 (26.93) 20 (48.79) 0.048
No 32 (78.04) 34 (69.38) 38 (73.07) 21 (51.21)
Treatment delay 4.45 ± 2.17 5.17 ± 2.21 4.76 ± 2.74 5.93 ± 5.56 ns
Mean PTA0.25–4 kHz
Pre-treatment 50.9 ± 18.65 63.25 ± 16.81 54.3 ± 18.37 105.7 ± 11.7 50.0001
Post-treatment 29.19 ± 16.28 45.83 ± 22.54 40.16 ± 22.6 84.41 ± 30.91 50.0001
ITS
Yes 8 (19.52) 14 (28.58) 21 (40.39) 13 (31.71) ns
No 33 (80.48) 35 (71.42) 31 (59.61) 28 (68.29)
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significant difference (p¼ 0.015) was also evidenced in case of PC,
with patients affected by downsloping hearing impairment having a
slight increase (20,000–30,000/ml) in mean PC with respect to
other groups. Concerning fibrinogen, aPTT, PT, Hb, WBC, Ht and
NLR, no significant variations between patients with different
audiogram shapes were identified (p40.05).
Finally, with the exception of fibrinogen, none of the main
haematological parameters studied resulted correlated with prog-
nosis; in fact, fibrinogen levels showed a significant positive trend
with prognosis (p¼ 0.041), with higher mean values found in
patients characterised by slight (329.48 ± 98.61 mg/dl) or no
(320.8 ± 78.61 mg/dl) improvement.
Discussion
Even if cochlear microcirculatory disturbances, viral, immunologic
and inflammatory reasons have been suggested as possible causes of
SSNHL, the exact etiopathogenesis of this otological emergency
remains still unclear.
In the last years, many authors studying the role of blood and
coagulation parameters as risk factors and potential prognostic
biomarkers for SSNHL, tried to understand the main pathogenetic
mechanism of hearing loss onset, often with contradictory
conclusions.
Platelet parameters (PC, MPV, PDW) are indexes of haemostasis
and its dysfunction and have been investigated as potential risk
factors for SSNHL due to its similar clinical manifestation to that of
vascular disorders. In particular, MPV is a well-studied indicator of
platelet activation: in fact, platelets of larger volume are
characterised by more granules, larger adhesion receptors and a
Figure 1. Pre-treatment and post-treatment PTA(0.25–4 kHz) in case of upsloping hearing loss (1), flat hearing loss (2) downsloping hearing
loss (3) and anacusis (4).
Figure 2. Relative frequencies of hearing recovery for each
audiogram shape group.
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higher enzymatic and metabolic activity (Park et al, 2001; Kamath
et al, 2002); so the presence of an elevated MPV may indicate
dysfunction of haemostasis and could support the hypothesis of
vascular impairment in the pathogenesis of SSNHL. Mirvakili et al
(2016) in a prospective case–control study showed no association
between PC, MPV and PDW and occurrence of SSNHL; only PDW
resulted correlated with the severity of hearing loss (p¼ 0.043). On
the contrary, Sagit et al (2013) and Seo et al (2014) analysing,
respectively, haematological data of 31 and 348 SSNHL patients
evidenced a significant difference in PC values between subjects
with and without SSNHL. Furthermore, Yasan et al (2013), Wittig
et al (2014), Quaranta et al (2015), Kum et al (2015) did not
recognise PC as prognostic factor for hearing recovery (p40.05).
WBC and its subtypes are well-known inflammatory markers in
cardiovascular diseases (Madjid et al, 2004), but, in patients
affected by SSNHL, a high WBC count may reflect immune-
mediated cochlear ischemic changes that can lead to extensive inner
ear tissue damage (Kanzaki et al, 2014). In particular, Seo et al
(2014) and Kum et al (2015) showed lower values of lymphocyte
count in patients with less than 15 dB HL of hearing gain with
respect to the initial hearing loss. Masuda et al (2012),
_Ikinciog˘ullar{ et al (2014) and Quaranta et al (2015) instead did
not observe any correlation between lymphocyte count and
recovery rate.
Other works instead, on the basis of fibrinogen rheological
properties, highlighted the association between high fibrinogen
levels and reduced blood flow in the inner ear with major risk of
SSNHL onset (Suckfull et al, 2002; Canis et al, 2012; Bao et al
2015). Quaranta et al (2015) did not find any significant difference
in terms of fibrinogen level between patients with and without
hearing improvement (p¼ 0.22). In contrast, Wittig et al (2014), in
a retrospective review including 173 SSNHL patients, recognised
hyperfibrinogenaemia as independent prognostic factors for better
hearing recovery (p¼ 0.032). Finally, Kanzaki et al (2014)
analysing the correlation between various potential blood factors
and hearing recovery rate demonstrated a negative correlation for
fibrinogen (p¼ 0.04) in case of high-pitch sloping hearing loss and
for WBC count (p¼ 0.03) in patients suffering from total deafness.
The analysis of our results may be summarised as follows: first,
in line with other studies (Zadeh et al, 2003; Cvorovic´ et al, 2008;
Kuhn et al, 2011), our data confirmed the association between
audiometric pattern and hearing recovery, with patients affected by
severe or profound hearing loss having poor prognosis (p¼ 0.0001).
Second, multivariate analysis failed to recognise a clear distinction
between different audiometric curves in terms of haematological
profile. In fact, of the 10 blood parameters examined, only higher
PC (p¼ 0.015) and lower L% (p¼ 0.041) values were found to be
statistically different in patients suffering from downsloping hearing
loss. Third, the study of fibrinogen levels evidenced different mean
values in patients suffering from upsloping hearing loss
(303.22 ± 61.53 mg/dl), flat hearing loss (332.48 ± 84.86 mg/dl),
downsloping hearing loss (296.4 ± 59.05 mg/dl) and anacusis
(324.58 ± 91.27 mg/dl), but without any significant difference.
However, in line with Kanzaki et al (2014), fibrinogen level
seems to influence the prognosis (p¼ 0.041); in fact, lower mean
values (5300 mg/dl) were found in patients characterised by marked
and complete recovery with respect to subjects who presented a
slight (329.48 ± 98.61 mg/dl) or no hearing improvement
(320.8 ± 78.61 mg/dl).
The main strength of our work is that it demonstrated a lack of
association between haematological parameters and a defined
audiological SSNHL picture. However, even if we tried to apply
strict criteria in the selection of patients to reduce the effect of
confounding factors, our results are limited by the retrospective
design and the relative small sample size of the study. Further
investigations are required to provide a clear evidence of our
suggestions.
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